胰岛素抵抗替代标志物与 50 岁以下人群结直肠腺瘤发生率之间的关系:一项单中心回顾性横断面研究

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Chi Hyeon Choi, Sang Yi Moon, Jong Yoon Lee
{"title":"胰岛素抵抗替代标志物与 50 岁以下人群结直肠腺瘤发生率之间的关系:一项单中心回顾性横断面研究","authors":"Chi Hyeon Choi, Sang Yi Moon, Jong Yoon Lee","doi":"10.3390/jpm14090971","DOIUrl":null,"url":null,"abstract":"<p><p>(1) Background: Young-onset colorectal adenomas (YOAs) are precursors to early-onset colorectal cancer, a growing concern among individuals under 50 years old. This study investigated the association between surrogate markers of insulin resistance (IR) and YOAs occurrence. (2) Methods: A retrospective cross-sectional analysis was conducted on 4467 individuals aged 20 to 49 years who underwent their first screening colonoscopy at Dong-A University Hospital from 2018 to 2022. IR was assessed using the triglyceride-glucose (TyG) index, triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C), and metabolic score for insulin resistance (METS-IR). (3) Results: Individuals with YOAs exhibited significantly higher median TyG index (8.51 ± 0.71 vs. 8.32 ± 0.61, <i>p</i> < 0.001), TG/HDL-C ratio (2.78 ± 3.05 vs. 2.12 ± 1.85, <i>p</i> < 0.001), and METS-IR (35.72 ± 8.37 vs. 33.44 ± 9.11, <i>p</i> < 0.001) values than controls. The adjusted odds ratios for YOAs were 1.064 (95% CI: 1.22-2.23, <i>p</i> = 0.021) for the TyG index, 1.067 (95% CI: 1.031-1.105, <i>p</i> < 0.001) for the TG/HDL-C ratio, and 1.011 (95% CI: 1.002-1.021, <i>p</i> = 0.023) for METS-IR values, indicating a strong association between higher IR marker values and the presence of YOAs. (4) Conclusions: Elevated IR marker values are strongly associated with the occurrence of YOAs in individuals under 50 years old.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"14 9","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11432768/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Relationship between Surrogate Markers of Insulin Resistance and Occurrence of Colorectal Adenoma in Individuals under 50 Years Old: A Single-Center Retrospective Cross-Sectional Study.\",\"authors\":\"Chi Hyeon Choi, Sang Yi Moon, Jong Yoon Lee\",\"doi\":\"10.3390/jpm14090971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>(1) Background: Young-onset colorectal adenomas (YOAs) are precursors to early-onset colorectal cancer, a growing concern among individuals under 50 years old. This study investigated the association between surrogate markers of insulin resistance (IR) and YOAs occurrence. (2) Methods: A retrospective cross-sectional analysis was conducted on 4467 individuals aged 20 to 49 years who underwent their first screening colonoscopy at Dong-A University Hospital from 2018 to 2022. IR was assessed using the triglyceride-glucose (TyG) index, triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C), and metabolic score for insulin resistance (METS-IR). (3) Results: Individuals with YOAs exhibited significantly higher median TyG index (8.51 ± 0.71 vs. 8.32 ± 0.61, <i>p</i> < 0.001), TG/HDL-C ratio (2.78 ± 3.05 vs. 2.12 ± 1.85, <i>p</i> < 0.001), and METS-IR (35.72 ± 8.37 vs. 33.44 ± 9.11, <i>p</i> < 0.001) values than controls. The adjusted odds ratios for YOAs were 1.064 (95% CI: 1.22-2.23, <i>p</i> = 0.021) for the TyG index, 1.067 (95% CI: 1.031-1.105, <i>p</i> < 0.001) for the TG/HDL-C ratio, and 1.011 (95% CI: 1.002-1.021, <i>p</i> = 0.023) for METS-IR values, indicating a strong association between higher IR marker values and the presence of YOAs. (4) Conclusions: Elevated IR marker values are strongly associated with the occurrence of YOAs in individuals under 50 years old.</p>\",\"PeriodicalId\":16722,\"journal\":{\"name\":\"Journal of Personalized Medicine\",\"volume\":\"14 9\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11432768/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Personalized Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jpm14090971\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm14090971","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

(1) 背景:早发性结直肠腺瘤(YOAs)是早发性结直肠癌的前兆,在 50 岁以下人群中日益受到关注。本研究调查了胰岛素抵抗(IR)的替代标记物与幼发大肠腺瘤发生率之间的关系。(2)方法:对2018年至2022年期间在东亚大学医院接受首次结肠镜筛查的4467名20至49岁的人进行了回顾性横断面分析。采用甘油三酯-葡萄糖(TyG)指数、甘油三酯-高密度脂蛋白胆固醇比值(TG/HDL-C)和胰岛素抵抗代谢评分(METS-IR)评估IR。(3) 结果:YOAs患者的TyG指数中值(8.51 ± 0.71 vs. 8.32 ± 0.61,p < 0.001)、TG/HDL-C比值(2.78 ± 3.05 vs. 2.12 ± 1.85,p < 0.001)和METS-IR(35.72 ± 8.37 vs. 33.44 ± 9.11,p < 0.001)均明显高于对照组。YOAs的调整后几率分别为:TyG指数为1.064(95% CI:1.22-2.23,p = 0.021),TG/HDL-C比值为1.067(95% CI:1.031-1.105,p < 0.001),METS-IR值为1.011(95% CI:1.002-1.021,p = 0.023)。(4)结论:在 50 岁以下的人群中,红外标志物值升高与 YOA 的发生密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Relationship between Surrogate Markers of Insulin Resistance and Occurrence of Colorectal Adenoma in Individuals under 50 Years Old: A Single-Center Retrospective Cross-Sectional Study.

(1) Background: Young-onset colorectal adenomas (YOAs) are precursors to early-onset colorectal cancer, a growing concern among individuals under 50 years old. This study investigated the association between surrogate markers of insulin resistance (IR) and YOAs occurrence. (2) Methods: A retrospective cross-sectional analysis was conducted on 4467 individuals aged 20 to 49 years who underwent their first screening colonoscopy at Dong-A University Hospital from 2018 to 2022. IR was assessed using the triglyceride-glucose (TyG) index, triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C), and metabolic score for insulin resistance (METS-IR). (3) Results: Individuals with YOAs exhibited significantly higher median TyG index (8.51 ± 0.71 vs. 8.32 ± 0.61, p < 0.001), TG/HDL-C ratio (2.78 ± 3.05 vs. 2.12 ± 1.85, p < 0.001), and METS-IR (35.72 ± 8.37 vs. 33.44 ± 9.11, p < 0.001) values than controls. The adjusted odds ratios for YOAs were 1.064 (95% CI: 1.22-2.23, p = 0.021) for the TyG index, 1.067 (95% CI: 1.031-1.105, p < 0.001) for the TG/HDL-C ratio, and 1.011 (95% CI: 1.002-1.021, p = 0.023) for METS-IR values, indicating a strong association between higher IR marker values and the presence of YOAs. (4) Conclusions: Elevated IR marker values are strongly associated with the occurrence of YOAs in individuals under 50 years old.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信